» Authors » Bjorn Corleis

Bjorn Corleis

Explore the profile of Bjorn Corleis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 590
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fricke C, Ulrich L, Kochmann J, Gergen J, Kovacikova K, Roth N, et al.
Mol Ther Nucleic Acids . 2024 Nov; 35(4):102360. PMID: 39524696
Coronavirus disease 2019 (COVID-19) mRNA vaccines that have contributed to controlling the SARS-CoV-2 pandemic induce specific serum antibodies, which correlate with protection. However, the neutralizing capacity of antibodies for emerging...
2.
Lett M, Otte F, Hauser D, Schon J, Kipfer E, Hoffmann D, et al.
NPJ Vaccines . 2024 Oct; 9(1):206. PMID: 39472701
Vaccines have played a central role in combating the COVID-19 pandemic, but newly emerging SARS-CoV-2 variants are increasingly evading first-generation vaccine protection. To address this challenge, we designed "single-cycle infection...
3.
Halwe N, Cool K, Breithaupt A, Schon J, Trujillo J, Nooruzzaman M, et al.
Nature . 2024 Sep; 637(8047):903-912. PMID: 39321846
In March 2024, highly pathogenic avian influenza virus (HPAIV) clade 2.3.4.4b H5N1 infections were reported in dairy cows in Texas, USA. Rapid dissemination to more than 380 farms in 14...
4.
Halwe N, Cool K, Breithaupt A, Schon J, Trujillo J, Nooruzzaman M, et al.
bioRxiv . 2024 Aug; PMID: 39149352
In March 2024, highly pathogenic avian influenza virus (HPAIV) clade 2.3.4.4b H5N1 infections in dairy cows were first reported from Texas, USA. Rapid dissemination to more than 190 farms in...
5.
Schon J, Barut G, Trueb B, Halwe N, Veiga I, Kratzel A, et al.
Nat Microbiol . 2024 Jul; 9(8):2099-2112. PMID: 38997518
Approved vaccines are effective against severe COVID-19, but broader immunity is needed against new variants and transmission. Therefore, we developed genome-modified live-attenuated vaccines (LAV) by recoding the SARS-CoV-2 genome, including...
6.
Papiez A, Pioch J, Mollenkopf H, Corleis B, Dorhoi A, Polanska J
PLoS One . 2024 Jun; 19(6):e0305874. PMID: 38917129
Combining data from experiments on multispecies studies provides invaluable contributions to the understanding of basic disease mechanisms and pathophysiology of pathogens crossing species boundaries. The task of multispecies gene expression...
7.
Eckhardt E, Schinkothe J, Gischke M, Sehl-Ewert J, Corleis B, Dorhoi A, et al.
Sci Rep . 2023 Dec; 13(1):22614. PMID: 38114538
No abstract available.
8.
Corleis B, Tzouanas C, Wadsworth 2nd M, Cho J, Linder A, Schiff A, et al.
Sci Transl Med . 2023 Dec; 15(725):eadg3451. PMID: 38055798
Tobacco smoking doubles the risk of active tuberculosis (TB) and accounts for up to 20% of all active TB cases globally. How smoking promotes lung microenvironments permissive to () growth...
9.
Eckhardt E, Schinkothe J, Gischke M, Sehl-Ewert J, Corleis B, Dorhoi A, et al.
Sci Rep . 2023 Oct; 13(1):18613. PMID: 37903877
The concept of donor-unrestricted T cells (DURTs) comprises a heterogeneity of lymphoid cells that respond to an abundance of unconventional epitopes in a non-MHC-restricted manner. Vaccinologists strive to harness this...
10.
Corleis B, Bastian M, Hoffmann D, Beer M, Dorhoi A
Front Immunol . 2023 Aug; 14:1223260. PMID: 37638020
Respiratory infections cause tremendous morbidity and mortality worldwide. Amongst these diseases, tuberculosis (TB), a bacterial illness caused by which often affects the lung, and coronavirus disease 2019 (COVID-19) caused by...